BioSpace News Archive

Abiomed (NASDAQ: ABMD) announces it has surpassed more than 1,000 patents worldwide, with more than 850 additional patents pending. Abiomed’s robust intellectual property portfolio protects its current and future pump and catheter designs, along with other product components such as motors, cannulas, sensors, software, and access devices. The portfolio also protects manufacturing processes and future artificial intellige

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced revisions to the REFINE-ALS biomarker study protocol to address the safety of people with amyotrophic lateral sclerosis (ALS) during the pandemic. The amendment gives patients the ability to consent to participate virtually, with the option to utilize telemedicine and

Alteogen Inc. (KOSDAQ:196170) announced today that it has entered into an exclusive license agreement with Intas Pharmaceuticals Ltd. to use ALT-B4, Alteogen’s novel hyaluronidase – derived utilizing the Hybrozyme™ technology – to develop and commercialize two products. Under the terms of the agreement, Alteogen has granted worldwide rights, except for a few Asian countries, for Intas to develop two products i

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 9:10 a.m. ET (6:10 a.m. PT). The audio portion of management’s remarks can be accessed live through Vertex’s website, www.vrtx.com , in the “Investors” section under the “News and Events” page. A replay of the conference webcast will be archived on the compa

Co-Diagnostics, Inc. announced that Company CEO Dwight Egan will participate in a panel discussion on diagnostics and devices hosted by Scott Gottlieb, M.D., at the H.C. Wainwright & Co. BioConnect 2021 Conference, being held January 11-14.

Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it will supply the U.S. Centers for Disease Control and Prevention (CDC) with a customized version of Twist SARS-CoV-2 Synthetic RNA Controls for use in the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay.

Standigm Inc. (“Standigm”), an artificial intelligence (AI)-based drug discovery company and SK Chemicals Co., Ltd. (“SK Chemicals”), a life science and green chemicals company, announce today that they have successfully found a new rheumatoid arthritis indication for an FDA-approved drug and have filed a patent.

Focus on Therapeutic Outcomes (FOTO), a Net Health Company, has been approved for the 13th consecutive year by the Centers for Medicare & Medicaid Services (CMS) as a data registry for CMS payment programs, and for the third consecutive year as a Qualified Clinical Data Registry (QCDR) for 2021.

Digital healthcare solutions refer to the use of information technology/electronic communication tools, services, and processes to deliver healthcare services or to facilitate better health.

Increasing demand for advanced and effective equipment and favorable government initiatives are expected to drive the nano healthcare technology market, finds Fact.MR in a new study.